Cite

HARVARD Citation

    Sun, J. et al. (2018). Taxifolin is a rat and human 11β-hydroxysteroid dehydrogenase 1 inhibitor as a possible drug to treat the metabolic syndrome. Journal of functional foods. pp. 181-187. [Online]. 
  
Back to record